Table 2 Number of eyes, median, and categories of visual acuity at the start of treatment.
From: Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Site | Aggregate | A | B | C | D | E | F | G | H | I | J | K | L | M |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyes (n) | 12,414 | 633 | 799 | 465 | 605 | 1353 | 839 | 1588 | 1416 | 1209 | 1084 | 835 | 832 | 756 |
Median baseline LogMAR (IQR) | 0.46 (0.26, 0.80) | 0.50 (0.30, 0.82) | 0.40 (0.20, 0.72) | 0.50 (0.26, 0.90) | 0.40 (0.22, 0.70) | 0.48 (0.22, 0.82) | 0.46 (0.30, 0.80) | 0.46 (0.30, 0.80) | 0.42 (0.22, 0.78) | 0.50 (0.26, 0.86) | 0.42 (0.28, 0.78) | 0.50 (0.30, 1.00) | 0.50 (0.30, 0.90) | 0.48 (0.30, 0.80) |
LogMAR ≤ 0.3 (%) | 34.5 | 26.9 | 43.8 | 36.1 | 38.7 | 34.6 | 32.9 | 35.0 | 38.4 | 32.3 | 32.7 | 32.8 | 35.0 | 27.9 |
LogMAR 0.32 to 0.58 (%) | 25.0 | 28.0 | 21.5 | 17.4 | 26.0 | 24.3 | 26.9 | 26.6 | 24.8 | 24.5 | 28.7 | 19.2 | 21.2 | 32.0 |
LogMAR 0.60 to 0.98 (%) | 23.0 | 26.5 | 22.0 | 24.5 | 22.8 | 24.4 | 23.6 | 21.2 | 21.7 | 23.9 | 24.3 | 20.0 | 22.7 | 23.7 |
LogMAR ≥ 1.0 (%) | 17.5 | 18.6 | 12.6 | 21.9 | 12.6 | 16.7 | 16.6 | 17.2 | 15.1 | 19.3 | 14.4 | 28.0 | 21.2 | 16.4 |
First eyes n (%) | 74.0 | 72.5 | 74.3 | 76.1 | 75.0 | 74.7 | 69.0 | 74.4 | 73.2 | 75.1 | 72.1 | 75.9 | 77.0 | 72.5 |
